Monocyte homing to the liver and adhesion to the liver sinusoidal endothelial cells (LSECs) are key elements in nonalcoholic steatohepatitis (NASH) pathogenesis. We reported previously that VCAM-1 mediates monocyte adhesion to LSECs. However, the pathogenic role of VCAM-1 in NASH is unclear. Herein, we report that VCAM-1 was a top upregulated adhesion molecule in the NASH mouse liver transcriptome. Open chromatin landscape profiling combined with genome-wide transcriptome analysis showed robust transcriptional upregulation of LSEC VCAM-1 in murine NASH. Moreover, LSEC VCAM-1 expression was significantly increased in human NASH. LSEC VCAM-1 expression was upregulated by palmitate treatment in vitro and reduced with inhibition of the mitogen-activated protein 3 kinase (MAP3K) mixed lineage kinase 3 (MLK3). Likewise, LSEC VCAM-1 expression was reduced in the Mlk3-/- mice with diet-induced NASH. Furthermore, VCAM-1 neutralizing Ab or pharmacological inhibition attenuated diet-induced NASH in mice, mainly via reducing the proinflammatory monocyte hepatic population as examined by mass cytometry by time of flight (CyTOF). Moreover, endothelium-specific Vcam1 knockout mice were also protected against NASH. In summary, lipotoxic stress enhances the expression of LSEC VCAM-1, in part, through MLK3 signaling. Inhibition of VCAM-1 was salutary in murine NASH and might serve as a potential therapeutic strategy for human NASH.

Department of Immunology

Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic Rochester Minnesota USA

Department of Pediatrics Charles University Prague Faculty of Medicine in Hradec Králové University Hospital Hradec Králové Czechia

Division of Experimental Pathology and Laboratory Medicine Department of Laboratory Medicine and Pathology and

Division of Gastroenterology and Hepatology

Division of Pediatric Gastroenterology Mayo Clinic Rochester Minnesota USA

Komentář v

J Clin Invest. 2021 Mar 15;131(6):147556. doi: 10.1172/JCI147556. PubMed

Zobrazit více v PubMed

Fazel Y, et al. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 2016;65(8):1017–1025. doi: 10.1016/j.metabol.2016.01.012. PubMed DOI

Younossi Z, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11–20. doi: 10.1038/nrgastro.2017.109. PubMed DOI

Friedman SL, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–922. doi: 10.1038/s41591-018-0104-9. PubMed DOI PMC

Ibrahim SH, et al. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut. 2018;67(5):963–972. doi: 10.1136/gutjnl-2017-315691. PubMed DOI PMC

Ritz T, et al. Dynamic plasticity of macrophage functions in diseased liver. Cell Immunol. 2018;330:175–182. doi: 10.1016/j.cellimm.2017.12.007. PubMed DOI

Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol. 2019;70(6):1278–1291. doi: 10.1016/j.jhep.2019.02.012. PubMed DOI

Miyao M, et al. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Lab Invest. 2015;95(10):1130–1144. doi: 10.1038/labinvest.2015.95. PubMed DOI

Hammoutene A, et al. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. J Hepatol. 2020;72(3):528–538. doi: 10.1016/j.jhep.2019.10.028. PubMed DOI

Guo Q, et al. Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. J Hepatol. 2019;71(6):1193–1205. doi: 10.1016/j.jhep.2019.07.019. PubMed DOI PMC

Taooka Y, et al. The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol. 1999;145(2):413–420. doi: 10.1083/jcb.145.2.413. PubMed DOI PMC

Carter RA, et al. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol. 2002;128(1):44–51. doi: 10.1046/j.1365-2249.2002.01794.x. PubMed DOI PMC

Park JG, et al. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 2013;226(2):356–363. doi: 10.1016/j.atherosclerosis.2012.11.029. PubMed DOI

Mahmoudi M, et al. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. Int J Rheum Dis. 2017;20(3):287–297. doi: 10.1111/1756-185X.12999. PubMed DOI

Totoson P, et al. Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Res Ther. 2014;16(1):202. PubMed PMC

Lefere S, et al. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. Int J Obes (Lond) 2017;41(8):1207–1213. doi: 10.1038/ijo.2017.102. PubMed DOI

Charlton M, et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol. 2011;301(5):G825–G834. doi: 10.1152/ajpgi.00145.2011. PubMed DOI PMC

Ley K, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–689. doi: 10.1038/nri2156. PubMed DOI

Miyachi Y, et al. Roles for cell-cell adhesion and contact in obesity-induced hepatic myeloid cell accumulation and glucose intolerance. Cell Rep. 2017;18(11):2766–2779. doi: 10.1016/j.celrep.2017.02.039. PubMed DOI

Hintermann E, Christen U. The many roles of cell adhesion molecules in hepatic fibrosis. Cells. 2019;8(12):1503. doi: 10.3390/cells8121503. PubMed DOI PMC

de Almeida IT, et al. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr. 2002;21(3):219–223. doi: 10.1054/clnu.2001.0529. PubMed DOI

Ibrahim SH, et al. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology. 2016;63(3):731–744. doi: 10.1002/hep.28252. PubMed DOI PMC

Ibrahim SH, et al. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Liver Int. 2014;34(3):427–437. doi: 10.1111/liv.12353. PubMed DOI PMC

Tomita K, et al. Mixed-lineage kinase 3 pharmacological inhibition attenuates murine nonalcoholic steatohepatitis. JCI Insight. 2017;2(15):94488. PubMed PMC

Dey A, et al. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol. 2014;5:683. PubMed PMC

Kazankov K, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–159. doi: 10.1038/s41575-018-0082-x. PubMed DOI

Li Z, et al. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005;42(4):880–885. doi: 10.1002/hep.20826. PubMed DOI

Ramachandran P, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575(7783):512–518. doi: 10.1038/s41586-019-1631-3. PubMed DOI PMC

Seidman JS, et al. Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity. 2020;52(6):1057–1074. doi: 10.1016/j.immuni.2020.04.001. PubMed DOI PMC

Kunsch C, et al. Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. J Pharmacol Exp Ther. 2004;308(3):820–829. doi: 10.1124/jpet.103.059733. PubMed DOI

Liu Z, et al. Novel ASK1 inhibitor AGI-1067 attenuates AGE-induced fibrotic response by suppressing the MKKs/p38 MAPK pathway in human coronary arterial smooth muscle cells. Int Heart J. 2018;59(6):1416–1424. doi: 10.1536/ihj.17-625. PubMed DOI

Sundell CL, et al. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent. J Pharmacol Exp Ther. 2003;305(3):1116–1123. doi: 10.1124/jpet.102.048132. PubMed DOI

Tardif JC, et al. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9626):1761–1768. doi: 10.1016/S0140-6736(08)60763-1. PubMed DOI

Lo MC, Lansang MC. Recent and emerging therapeutic medications in type 2 diabetes mellitus: incretin-based, Pramlintide, Colesevelam, SGLT2 Inhibitors, Tagatose, Succinobucol. Am J Ther. 2013;20(6):638–653. doi: 10.1097/MJT.0b013e3181ec9eb2. PubMed DOI

Kong DH, et al. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018;19(4):1057. doi: 10.3390/ijms19041057. PubMed DOI PMC

Alva JA, et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn. 2006;235(3):759–767. doi: 10.1002/dvdy.20643. PubMed DOI

Dzierzak E, Speck NA. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat Immunol. 2008;9(2):129–136. doi: 10.1038/ni1560. PubMed DOI PMC

Monvoisin A, et al. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium. Dev Dyn. 2006;235(12):3413–3422. doi: 10.1002/dvdy.20982. PubMed DOI

Matsumoto M, et al. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013;94(2):93–103. doi: 10.1111/iep.12008. PubMed DOI PMC

Zhao P, et al. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science. 2020;367(6478):652–660. doi: 10.1126/science.aay0542. PubMed DOI PMC

Carambia A, et al. TGF-β-dependent induction of CD4(+)CD25(+)Foxp3(+) Tregs by liver sinusoidal endothelial cells. J Hepatol. 2014;61(3):594–599. doi: 10.1016/j.jhep.2014.04.027. PubMed DOI

Kar S, et al. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLoS One. 2019;14(7):e0217263. doi: 10.1371/journal.pone.0217263. PubMed DOI PMC

Neish AS, et al. Endothelial interferon regulatory factor 1 cooperates with NF-κ B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol. 1995;15(5):2558–2569. doi: 10.1128/MCB.15.5.2558. PubMed DOI PMC

Ahmad M, et al. Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J Biol Chem. 1998;273(8):4616–4621. doi: 10.1074/jbc.273.8.4616. PubMed DOI

Tomita K, et al. Mixed lineage kinase 3 mediates the induction of CXCL10 by a STAT1-dependent mechanism during hepatocyte lipotoxicity. J Cell Biochem. 2017;118(10):3249–3259. doi: 10.1002/jcb.25973. PubMed DOI PMC

Krishnan A, et al. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol. 2017;312(6):G666–G680. doi: 10.1152/ajpgi.00213.2016. PubMed DOI PMC

Geraud C, et al. Endothelial transdifferentiation in hepatocellular carcinoma: loss of Stabilin-2 expression in peri-tumourous liver correlates with increased survival. Liver Int. 2013;33(9):1428–1440. doi: 10.1111/liv.12262. PubMed DOI

Poisson J, et al. Liver sinusoidal endothelial cells: physiology and role in liver diseases. J Hepatol. 2017;66(1):212–227. doi: 10.1016/j.jhep.2016.07.009. PubMed DOI

Rogers GW, et al. Decreased hepatic uptake of cholesterol and retinol in the dimethylnitrosamine rat model of cirrhosis. Liver. 1992;12(5):326–329. PubMed

Furuta K, et al. Emerging roles of liver sinusoidal endothelial cells in nonalcoholic steatohepatitis. Biology (Basel) 2020;9(11):E395. PubMed PMC

Corces MR, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14(10):959–962. doi: 10.1038/nmeth.4396. PubMed DOI PMC

Yan H, et al. HiChIP: a high-throughput pipeline for integrative analysis of ChIP-Seq data. BMC Bioinformatics. 2014;15(1):280. doi: 10.1186/1471-2105-15-280. PubMed DOI PMC

Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–1760. doi: 10.1093/bioinformatics/btp324. PubMed DOI PMC

Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS) Genome Biol. 2008;9(9):R137. doi: 10.1186/gb-2008-9-9-r137. PubMed DOI PMC

Ross-Innes CS, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481(7381):389–393. doi: 10.1038/nature10730. PubMed DOI PMC

Becher B, et al. High-dimensional analysis of the murine myeloid cell system. Nat Immunol. 2014;15(12):1181–1189. doi: 10.1038/ni.3006. PubMed DOI

Wong MT, et al. Mapping the diversity of follicular helper T cells in human blood and tonsils using high-dimensional mass cytometry analysis. Cell Rep. 2015;11(11):1822–1833. doi: 10.1016/j.celrep.2015.05.022. PubMed DOI

Chen H, et al. Cytofkit: a bioconductor package for an integrated mass cytometry data analysis pipeline. PLoS Comput Biol. 2016;12(9):e1005112. doi: 10.1371/journal.pcbi.1005112. PubMed DOI PMC

Hilscher MB, et al. Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension. Gastroenterology. 2019;157(1):193–209. doi: 10.1053/j.gastro.2019.03.013. PubMed DOI PMC

Pitulescu ME, et al. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat Protoc. 2010;5(9):1518–1534. doi: 10.1038/nprot.2010.113. PubMed DOI

Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis